Enhanced survival of primary murine dopaminergic neurons induced by a partially purified cell lysate fraction from mouse-derived striatal hybrid monoclonal cells

Neuroscience Letters

Volumn 353, Issue 2, 2003, Pages 83-86

  Won, Lisa ^a   Bubula, Nancy ^a   Hessefort, Suzanne ^a   Gross, Martin ^a   Heller, Alfred ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cell lines; Dopamine; MN9D; Nigrostriatal; Parkinson's disease; Reaggregate culture; Trophic factor

Indexed keywords

CELL PROTEIN; DOPAMINE; HOMOVANILLIC ACID; TROPHIC FACTOR; ULTRAFILTRATE FRACTION OF THE LYSATE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DENSITY; CELL FRACTIONATION; CELL LINE; CELL LOSS; CELL LYSATE; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; HYBRID CELL; MESENCEPHALON; MOUSE; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; TARGET CELL; ULTRAFILTRATION;

EID: 0344234419     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.08.081     Document Type: Article

References (13)

1. Choi H.K., Won L.A., Kontur P.J., Hammond D.N., Fox A.P., Wainer B.H., Hoffmann P.C., Heller A. Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res. 552:1991;67-76.
2. Heller A., Choi H., Won L. Regulation of developing dopaminergic axonal arbor size in three-dimensional reaggregate tissue culture. J. Comp. Neurol. 384:1997;349-358.
3. Heller A., Freeney A., Hessefort S., Villereal M., Won L. Cellular dopamine is increased following exposure to a factor derived from immortalized striatal neurons. Neurosci. Lett. 295:2000;1-4.
4. Heller A., Gross M., Hessefort S., Bubula N., Won L. Dopaminergic stimulatory polypeptides from immortalized striatal cells. Ann. N. Y. Acad. Sci. 991:2003;339-341.
5. Heller A., Hoffmann P., Wainer B. Enhancement of dopamine neuron survival and axonal proliferation by membranes from striatal target cells. Soc. Neurosci. Abstr. 9:1983;10.
6. Heller A., Won L., Choi H., Heller B., Hoffmann P.C. Reaggregate cultures. Tyson C.A., Frazier J.M. Methods in Toxicology. Methods in Toxicology. 1:1993;27-45 Academic Press, New York.
7. Heller A., Won L., Choi H., Wainer B., Hoffmann P. Neuronal hybrid cell lines: generation, characterization, and utility. Gage F., Christen Y. Second National Parkinson Foundation Conference on Advances in Parkinson Research. 1992;69-81 Futura, New York.
8. Heller B., Schweingruber F., Guvenc D., Heller A. Computer experiments to determine whether over- or under-counting necessarily affects the determination of difference in cell number between experimental groups. J. Neurosci. Methods. 91:2001;91-99.
9. Jellinger K.A. The pathology of Parkinson's disease. Calne D., Calne S. Parkinson's Disease: Advances in Neurology. 86:2001;55-72 Lippincott Williams & Wilkins, Philadelphia, PA.
10. Kotake C., Hoffmann P.C., Heller A. The biochemical and morphological development of differentiating dopamine neurons co-aggregated with their target cells of the corpus striatum in vitro. J. Neurosci. 2:1982;1307-1315.
11. Moore R.Y., Bhatnagar R.K., Heller A. Anatomical and chemical studies of a nigro-neostriatal projection in the cat. Brain Res. 30:1971;119-135.
12. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85.
13. Wainwright M.S., Perry B.D., Won L.A., O'Malley K.L., Wang W.Y., Ehrlich M.E., Heller A. Immortalized murine striatal neuronal cell lines expressing dopamine receptors and cholinergic properties. J. Neurosci. 15:1995;676-688.